Related Experiment Videos
HL-A-antigens, schizophrenia and brain atrophy
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
BAY 81-8973, a full-length recombinant factor VIII: results from an International comparative laboratory field study.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
Chromogenic assay for BAY 81-8973 potency assignment has no impact on clinical outcome or monitoring in patient samples.
Journal of thrombosis and haemostasis : JTH·2016
Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II).
Journal of thrombosis and haemostasis : JTH·2014
An iguratimod prodrug reduces RA-FLS invasiveness by disrupting STAT1-C3-TNFα-mediated crosstalk between fibroblast-like synoviocytes and macrophages.
Journal of orthopaedic translation·2026
Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry.
Frontiers in pharmacology·2026
Primary adrenal epithelioid angiosarcoma: An extraordinarily rare malignancy with a challenging diagnosis.
Radiology case reports·2026
Utility of monocyte-derived cells to investigate immune-mediated drug-induced liver injury.
Toxicology letters·2026